VXRT shares fall on plans to delay COVID-19 clinical trials (NASDAQ:VXRT) by Technical Terrence Team 03/15/2023 0 aajan Issuing its fourth-quarter 2022 financial data on Wednesday, vaccine developer Vaxart (NASDAQ:VXRT) announced a reorganization of its portfolio to ...